Kolinpharma obtains its 40th patent, first for Miledix

Miledix is a food supplement formulated with specific ingredients useful for counteracting menstrual cycle disorders

Rita Paola Petrelli, President of Kolinpharma, commented: "The granting of a patent represents a very important element for us both because it recognizes the uniqueness and technological innovation of the product and therefore the goodness of the activity of our R&D department, both on a commercial level by attributing greater visibility and enhancement to the products themselves.

"Today we receive the fifth patent in Italy and we are particularly satisfied as it represents the first recognition for the Miledix product which continues to establish itself on the domestic market."

Read More